Holen Sie sich die Stockscreener-App
10.76
1.03%
0.11
Lyell Immunopharma Inc Aktie (LYEL) Neueste Nachrichten
Trendlines Converge — Decision Point for Lyell Immunopharma Inc.Trade Volume Summary & Free High Return Stock Watch Alerts - classian.co.kr
Lyell Immunopharma Inc. Could See a Relief Rally From SupportWeekly Market Report & Free Weekly Watchlist of Top Performers - thegnnews.com
Can Lyell Immunopharma Inc. reach all time highs this yearMarket Activity Report & Daily Entry Point Alerts - 선데이타임즈
What machine learning models say about Lyell Immunopharma Inc.Weekly Market Outlook & Daily Price Action Insights - Newser
Custom strategy builders for tracking Lyell Immunopharma Inc.2025 Technical Patterns & Free Expert Approved Momentum Trade Ideas - Newser
Detecting price anomalies in Lyell Immunopharma Inc. with AIWeekly Trade Recap & High Conviction Investment Ideas - Newser
Is Lyell Immunopharma Inc. stock poised for growthPortfolio Gains Report & Long Hold Capital Preservation Plans - Newser
Real time scanner hits for Lyell Immunopharma Inc. explained2025 Performance Recap & Free Technical Confirmation Trade Alerts - Newser
What’s next for Lyell Immunopharma Inc. stock priceTrade Analysis Summary & Daily Profit Maximizing Tips - Newser
Relative strength of Lyell Immunopharma Inc. in sector analysisJuly 2025 Macro Moves & High Conviction Buy Zone Alerts - Newser
Applying big data sentiment scoring on Lyell Immunopharma Inc.2025 Institutional Moves & Verified Entry Point Signals - Newser
Will Lyell Immunopharma Inc. benefit from green energy policies2025 Stock Rankings & Consistent Income Trade Ideas - thegnnews.com
Will earnings trigger a reversal in Lyell Immunopharma Inc.Trend Reversal & Reliable Trade Execution Plans - Newser
Analyzing recovery setups for Lyell Immunopharma Inc. investorsTreasury Yields & Low Drawdown Trading Techniques - Newser
How to escape a deep drawdown in Lyell Immunopharma Inc.2025 Year in Review & Free High Accuracy Swing Entry Alerts - Newser
Lyell Immunopharma (NASDAQ:LYEL) Cut to Strong Sell at Wall Street Zen - Defense World
Sectors Driving Future Growth for Lyell Immunopharma Inc. Stock2025 Year in Review & Reliable Volume Spike Trade Alerts - Newser
How to use a screener to detect Lyell Immunopharma Inc. breakoutsTrade Volume Summary & Verified Technical Trade Signals - Newser
A | Can Lyell Immunopharma, Inc. Rally Enough to Break Even?2025 Market Sentiment & Long-Term Safe Return Strategies - newsyoung.net
Intraday pattern recognizer results for Lyell Immunopharma Inc.Earnings Risk Report & Detailed Earnings Play Strategies - Newser
What is the Moat Score of Lyell Immunopharma Inc.2025 Fundamental Recap & Fast Exit/Entry Strategy Plans - sundaytimes.kr
Lyell Immunopharma Secures $100M, Reports Promising LYL314 Results, and Cuts Net Loss in Q2 2025 - AInvest
Lyell Immunopharma Sells 3.75M Shares of Common Stock for Holders. - AInvest
Lyell Immunopharma Advances CAR T-Cell Therapies - TipRanks
Lyell Immunopharma COO Hill sells $1.9k in shares By Investing.com - Investing.com Nigeria
Lyell Immunopharma COO Hill sells $1.9k in shares - Investing.com India
Lyell Immunopharma CSO sells $2.8k in shares By Investing.com - Investing.com Nigeria
Lyell Immunopharma CFO Newton sells shares worth $2.7k By Investing.com - Investing.com Australia
Lyell Immunopharma CFO Newton sells shares worth $2.7k - Investing.com
Lyell Immunopharma CEO Seely sells shares worth $8k By Investing.com - Investing.com UK
Can you recover from losses in Lyell Immunopharma Inc.Gold Moves & Low Risk High Reward Trade Ideas - Newser
Lyell Immunopharma shares rise 1.04% intraday despite reporting a $42.7 million loss in Q2. - AInvest
Lyell Immunopharma: Q2 Earnings Snapshot - New Haven Register
Identifying reversal signals in Lyell Immunopharma Inc.July 2025 Chart Watch & AI Forecasted Entry and Exit Points - Newser
Will Lyell Immunopharma Inc. rebound enough to break evenMarket Performance Recap & Fast Gaining Stock Strategy Reports - Newser
Lyell Immunopharma 2025 Q2 Earnings Slight Improvement in Losses Amid Revenue Drop - AInvest
Forex Signals Brief for Aug 13: Cisco, Trump Media, Lyell Earnings in Focus - FXLeaders
Regression analysis insights on Lyell Immunopharma Inc. performanceReal-Time Setup Summary with ROI Focus - Newser
Lyell Immunopharma Reports Positive Clinical Data, $100mln Private Placement. - AInvest
Lyell Immunopharma's Share Sale and Its Implications for Market Confidence and Capital Flexibility - AInvest
Lyell Immunopharma Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2025 - GlobeNewswire
Lyell's New Lymphoma Treatment Outperforms Current CAR T-Cell Therapies with Superior Response Rates - Stock Titan
What technical models suggest about Lyell Immunopharma Inc.’s comebackChart-Based Entry Confirmation for Beginners - Newser
How Lyell Immunopharma Inc. stock performs during market volatilityHigh Yield Growth Opportunities - mustnews.co.kr
0.94%
1.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):